RE:RE:RE:Sell-offHowever, to keep the discussion balanced, I'll note that arguments the other way exist:
(1) potential for a 4th wave of COVID-19 arising from nCOV variants
(2) fall in value of the USD
(3) pre-existing royalties likely static in aggregate for 2021 due to weighted resets from 2020 performance netting out to zero ... royalty growth expected only from recent/new investments
(4) meaningful dividend increase counter-indicated by (2), (3), and a statement from management on the last quarterly call (they like the new payout ratio after cutting the dividend).
(5) the new tax treatment, announced in March/2021, will discourage many investors from holding Alaris in a non-registered account.
.
born2trade wrote: Under 16, it seems a decent buy considering 8% current yield with potential increase in next few quarters and target price north of $20 in a year . This eqates to total ROI of 30- 35% . Not bad in the current environment .